All Updates

All Updates

icon
Filter
Partnerships
Optimi Health and Mind Medicine Australia launch OptiMed for psychiatrists
Psychedelic Medicine
Jun 27, 2024
This week:
Partnerships
Sheeva.AI and P97 Networks partner for in-car payment solutions at fuel stations
Auto Tech
Today
Product updates
Food Cycle Science launches 'Food Cycler Eco 3,' a household food waste processing bin
Food Waste
Yesterday
Partnerships
Von Holzhausen and Herman Miller partner to launch plant-based leather Eames Chair
Bio-based Materials
Yesterday
Partnerships
Volvo Cars partners with Beijing Shougang and Zhejiang Yiyun for automotive steel recycling
Waste Recovery & Management Tech
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Carbon Capture, Utilization & Storage (CCUS)
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Alternative Energy
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
Pet Care Tech
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
InsurTech: Personal Lines
Yesterday
M&A
Applied Systems acquires Planck for undisclosed sum to expand AI capabilities
InsurTech: Infrastructure
Yesterday
Product updates
Monzo launches pension consolidation product
Neobanks
Yesterday
Psychedelic Medicine

Psychedelic Medicine

Jun 27, 2024

Optimi Health and Mind Medicine Australia launch OptiMed for psychiatrists

Partnerships

  • Canada-based psychedelic drug manufacturer Optimi Health has partnered with Mind Medicine Australia to launch a resource platform for Australian psychiatrists called "OptiMed."

  • The OptiMed Prescriber Portal offers comprehensive resources, secure communication tools, multimedia, and regulatory guidance on psilocybin and MDMA drug candidates.

  • Supported by Optimi and Mind Medicine Australia staff, the platform aims to facilitate the safe and effective prescription of psychedelic medicines through the Authorised Prescriber Scheme in Australia. It is exclusive to Australian psychiatrists, with plans for expansion to other countries as local regulations permit.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.